###begin article-title 0
###xml 32 40 <span type="species:ncbi:9606">Children</span>
Urinary Eosinophil Protein X in Children with Atopic Asthma
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 377 379 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 554 555 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 562 564 561 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 636 638 635 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 671 678 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 734 735 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 737 738 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 747 748 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 818 820 817 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 835 836 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 845 846 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 915 917 914 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 956 966 955 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 212 220 <span type="species:ncbi:9606">children</span>
###xml 301 309 <span type="species:ncbi:9606">children</span>
###xml 661 669 <span type="species:ncbi:9606">children</span>
###xml 1101 1109 <span type="species:ncbi:9606">children</span>
The aim of this study was to investigate the relationship between urinary eosinophil protein X (uEPX) and asthma symptoms, lung function, and other markers of eosinophilic airway inflammation in asthmatic school children. Methods. A cross-sectional study was performed in 180 steroid dependent atopic children with stable moderately severe asthma, who were stable on 200 or 500mug of fluticasone per day. uEPX was measured in a single sample of urine and was normalized for creatinine concentration (uEPX/c). Symptom scores were kept on a diary card. FEV1 and PD20 methacholine were measured. Sputum induction was performed in 49 and FENO levels measured in 24 children. Results. We found an inverse correlation between uEPX/c and FEV1 (r = -.20, P = .01) and a borderline significant correlation between uEPX/c and PD20 methacholine (r = -.15, P = .06). Symptom score, %eosinophils and ECP in induced sputum and FENO levels did not correlate with uEPX/c. Conclusion. uEPX/c levels did not correlate with established markers of asthma severity and eosinophilic airway inflammation in atopic asthmatic children.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 535 537 535 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 104 112 <span type="species:ncbi:9606">children</span>
Eosinophilic airway inflammation is the pathological substrate of allergic asthma both in adults and in children [1, 2]. The severity of airway inflammation correlates poorly with symptoms and lung function [3]. As asthma treatment with inhaled steroids aims at reducing inflammation, there is a need to monitor the disease with a marker of inflammation [4, 5]. Potential markers are serum eosinophilic cationic protein (ECP), induced sputum cellularity and soluble markers [6], and the concentration of nitric oxide in exhaled air (FENO) [7, 8].
###end p 4
###begin p 5
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 301 309 <span type="species:ncbi:9606">children</span>
###xml 572 580 <span type="species:ncbi:9606">children</span>
Eosinophil protein X (EPX) is one of the toxic proteins present in eosinophil granules and is released by activated eosinophils. EPX can be measured accurately in urine (uEPX) [9]. Therefore, uEPX can be regarded as a marker of eosinophil degranulation in vivo [10]. uEPX levels in allergic asthmatic children were found to be significantly higher than in healthy controls [11-14]. Treatment with inhaled steroids reduced uEPX levels [14]. We hypothesized that measuring EPX in urine could potentially prove to be useful for monitoring eosinophilic airway inflammation in children and may complement other markers of asthma control such as symptom scores and lung function.
###end p 5
###begin p 6
###xml 185 187 185 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
The aim of this study was to evaluate the relationship between uEPX and current symptoms and lung function parameters, and the relation between uEPX, induced sputum eosinophilia, and FENO. For this purpose, we analyzed cross-sectional data obtained at enrolment for a multicentre trial.
###end p 6
###begin title 7
2. METHODS
###end title 7
###begin title 8
2.1. Subjects
###end title 8
###begin p 9
###xml 713 715 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 715 716 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 717 718 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 720 721 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 736 738 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 738 739 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 740 741 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 743 744 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 52 60 <span type="species:ncbi:9606">children</span>
###xml 133 141 <span type="species:ncbi:9606">Children</span>
###xml 251 259 <span type="species:ncbi:9606">children</span>
###xml 768 776 <span type="species:ncbi:9606">children</span>
Data were obtained from steroid-dependent asthmatic children who took part in a large randomized controlled multicentre trial (CATO: Children Asthma Therapy Optimal). One hundred and eighty atopic (RAST >/= class 1 for at least one airborne allergen) children, median age 10.3 years (range 6-16 years), with a documented clinical history of moderately severe asthma were recruited from paediatric clinics in 8 general hospitals and 7 university hospitals in The Netherlands. All had been treated with inhaled corticosteroids (ICS) for at least 4 weeks. Data were obtained during a clinic visit at the end of the run in period of 4-12 weeks. During this period, they were treated with fluticasone dipropionate 200 mug/d (n = 102) or 500 mug/d (n = 78). All parents and children if >12 years gave their written informed consent. The study was approved by the medical ethics committees of all participating hospitals.
###end p 9
###begin title 10
2.2. Symptom scores
###end title 10
###begin p 11
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Two weeks before visiting the hospital, patients kept a diary in which symptoms (shortness of breath, wheeze, and cough) were scored twice a day each on a 4-point (0-3) scale. Cumulative symptom scores were calculated over 14 days (maximum score 252).
###end p 11
###begin title 12
2.3. Fractional exhaled nitric oxide
###end title 12
###begin p 13
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
The fractional concentration of exhaled nitric oxide (FENO) was measured with the online single breath method, using the NIOX NO-analyzer (Aerocrine, Stockholm, Sweden) according to ERS/ATS guidelines [15].
###end p 13
###begin p 14
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 107 109 107 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 86 94 <span type="species:ncbi:9606">children</span>
As FENO could only be measured in 1 participating university centre, only part of the children underwent FENO measurements.
###end p 14
###begin title 15
2.4. Flow-volume curves
###end title 15
###begin p 16
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
Flow-volume curves and forced expiratory volume in 1 second (FEV1) were measured on a dry rolling seal spirometer according to recommendations [16]. Results are expressed as percentage of predicted values [17].
###end p 16
###begin title 17
2.5. Bronchial challenge test
###end title 17
###begin p 18
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 76 78 76 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 137 138 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 263 264 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Bronchial responsiveness was determined by a methacholine challenge [18]. PD20 methacholine (provocative dose of methacholine causing FEV1 fall 20% from baseline) was assessed by linear interpolation of the last two points of the log dose-response curve where FEV1 had fallen below 20% of baseline value.
###end p 18
###begin title 19
2.6. Sputum induction and processing
###end title 19
###begin p 20
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Sputum induction was performed by 5 university centres and 3 paediatric clinics in general hospitals. Sputum was induced according to a standardized method by inhaling an aerosol prepared from hypertonic sodium chloride 4.5% w/v [19, 20]. Differential cell counts of the cytospins were performed by counting 500 cells. Sputum samples containing more than 80% squamous cells were excluded from the analysis [20].
###end p 20
###begin p 21
In sputum supernatant, ECP was measured by fluoroenzyme immunoassay (Pharmacia, Uppsala, Sweden).
###end p 21
###begin title 22
2.7. Urinary eosinophil protein X
###end title 22
###begin p 23
###xml 556 558 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 558 559 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 199 204 <span type="species:ncbi:9606">human</span>
A spot sample urine was collected from each individual at the clinic visit and immediately stored at -20degreesC. uEPX was determined using a commercial enzyme-linked immunosorbent assay (ELISA) for human EPX in 50-fold diluted samples according to the manufacturers recommendations (Medical and Biological Laboratories, Naka-Ku Nagoya, Japan). The sensitivity of the assay was 0.62ng/mL. Urinary creatinine levels were measured by using the alkaline picrate method (Jaffe reaction) (Roche, Mannheim, Germany). Urinary EPX concentrations were expressed as mug per mmol creatinine (uEPX/c).
###end p 23
###begin title 24
2.8. Data analysis
###end title 24
###begin p 25
###xml 65 67 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All variables with a non-Gaussian distribution (symptom score, PD20 methacholine, FENO, % eosinophils in sputum, ECP in sputum, and uEPX) could be normalized by log-transformation. The significance of the relation between uEPX and lung function variables or other markers of inflammation was calculated using Spearman's rank correlation coefficients. A two-sided P value of <.05 was considered statistically significant.
###end p 25
###begin title 26
3. RESULTS
###end title 26
###begin p 27
###xml 119 121 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 121 122 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 128 129 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 144 146 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 146 147 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 153 154 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 37 41 <span type="species:ncbi:9606">boys</span>
One hundred and eighty subjects (105 boys (58.3%)) participated. Asthma was controlled by fluticasone dipropionate 200 mug/day (n = 102) or 500 mug/day (n = 78).
###end p 27
###begin p 28
###xml 102 106 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 267 268 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 345 349 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 390 391 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 644 646 638 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 648 649 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 72 80 <span type="species:ncbi:9606">children</span>
###xml 209 217 <span type="species:ncbi:9606">children</span>
###xml 323 331 <span type="species:ncbi:9606">Children</span>
All subjects performed spirometry and recorded symptoms in a diary. Six children inhaled short-acting beta-agonists prior to the visit, their results were excluded from analysis. One hundred and seventy eight children performed a bronchial challenge test; two had FEV1 < 80% of personal best and were therefore not tested. Children who had used beta-agonist within 8 hours before the test (n = 6) were again excluded. For logistic reasons, sputum induction was done in part of the subjects. Forty nine of the 98 sputum inductions yielded adequate sputum samples (50%). At randomization, only one university centre had the facility to measure FENO (n = 24 subjects).
###end p 28
###begin p 29
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 152 154 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 154 155 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 186 188 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 188 189 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 272 276 <span type="species:ncbi:9606">boys</span>
###xml 281 286 <span type="species:ncbi:9606">girls</span>
Baseline results of lung function, symptom score, and markers of inflammation are given in Table 1. uEPX/c showed a log-normal distribution, median 185 mug/mmol creatinine (range 2-3114 mug/mmol creatinine). UEPX/c did not correlate with age and was not different between boys and girls.
###end p 29
###begin title 30
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
3.1. Relation between uEPX/c and clinical markers of asthma severity (Table 2)
###end title 30
###begin p 31
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 154 162 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 261 263 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 263 264 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 305 307 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 307 308 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 317 318 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 362 363 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 473 475 471 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 517 518 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 527 528 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 242 250 <span type="species:ncbi:9606">children</span>
UEPX/c did not correlate with symptom scores or inhaled steroid dose. There was a significant inverse correlation of uEPX/c with FEV1(r = -.18, P = .02) (Figure 1). The association between uEPX/c and FEV1 did not significantly differ between children using 200 mug fluticasone per day and those using 500 mug (Anova, P = .19). For each 10% points increase of FEV1 (pred. %) the geometric mean EPX/c ratio decreases 18% (95% CI: 5,30%). The correlation between uEPX/c and PD20 methacholine was borderline significant (r = -.14, P = .08).
###end p 31
###begin title 32
###xml 73 80 73 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
3.2. Relation between uEPX and markers of asthmatic airway inflammation (Table 2)
###end title 32
###begin p 33
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 117 119 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
uEPX/c did not correlate with the % eosinophils or ECP in induced sputum, or with FENO. Relations between uEPX and PD20 methacholine or markers of asthmatic airway inflammation did not significantly differ when analysis was adjusted for fluticasone dose.
###end p 33
###begin p 34
###xml 31 39 <span type="species:ncbi:9606">children</span>
Correlations were similar when children with eczema were excluded from the analysis.
###end p 34
###begin title 35
4. DISCUSSION
###end title 35
###begin p 36
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 363 365 363 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 156 164 <span type="species:ncbi:9606">children</span>
We found a significant correlation of uEPX/c and FEV1, and no association between uEPX/c and bronchial responsiveness or symptom scores in a large group of children with moderately severe allergic asthma. In subgroups, no significant correlations between uEPX/c and other markers of eosinophilic airways inflammation (% eosinophils and ECP in induced sputum or FENO) were found.
###end p 36
###begin p 37
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 800 801 800 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 925 926 925 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1331 1333 1331 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 134 142 <span type="species:ncbi:9606">children</span>
###xml 288 296 <span type="species:ncbi:9606">children</span>
###xml 473 481 <span type="species:ncbi:9606">children</span>
This is the first study reporting uEPX/c levels in relation with markers of asthma severity and inflammation in a large population of children with atopic asthma, treated with inhaled steroids. Lugosi et al. have shown that uEPX levels were increased in symptomatic versus nonsymptomatic children with asthma, treated with inhaled steroids or disodium cromoglycate [21], and Oosaki et al. [22] found significantly elevated uEPX levels during acute asthma exacerbationss in children. All subjects included in our study had stable well-controlled asthma, as evidenced by a median cumulative symptom score of only 17 of a maximum of 252. Conflicting data have been published on the association between uEPX/c and pulmonary function tests [21, 23]. We found a significant negative correlation between FEV1 and uEPX/c. It should be mentioned that the scatter was wide, and individual uEPX/c therefore varied widely for a given FEV1 level. Hence, such correlations are unlikely to be detected in smaller groups. However, the within-subject variation of both parameters in time had not been studied. We confirmed our hypothesis that uEPX/c and bronchial hyperresponsiveness are not closely correlated. Lack of correlation between the severity of bronchial hyperresponsiveness and uEPX/c levels was also reported in 3 previous studies [24-26]. A close correlation between bronchial hyperresponsiveness and uEPX/c was not expected, because bronchial hyperresponsiveness is multifactorial and is not only caused by (eosinophilic) airways inflammation, but also by airway geometry, airway remodelling, and autonomic dysregulation.
###end p 37
###begin p 38
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 660 662 660 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 612 620 <span type="species:ncbi:9606">children</span>
Our hypothesis that uEPX/c would correlate with markers of eosinophilic airway inflammation could not be confirmed, as we found no correlation between uEPX/c and the percentage eosinophils in induced sputum. Others likewise found no correlation between uEPX/c and bronchoalveolar lavage cell counts in adult asthmatic patients [10]. An alternative explanation for not finding significant correlations between percentages of sputum eosinophils and uEPX/c could be that uEPX is only released by activated eosinophils, whereas in sputum we counted activated as well as nonactivated eosinophils. Also, the number of children from whom suitable sputum samples or FENO values were obtained was relatively small.
###end p 38
###begin p 39
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 179 187 <span type="species:ncbi:9606">children</span>
We found no correlation between uEPX/c and sputum ECP levels. In contrast, Mattes et al. [11] reported a positive correlation between uEPX/c and sputum ECP in 25 stable asthmatic children on inhaled corticosteroids. They found much higher ECP concentrations than we did (median 453ng/mL, range 40-2600; and 29ng/ml, 1-2345, resp.). The reason for this is not clear, but may be related to different sputum processing techniques.
###end p 39
###begin p 40
One could argue that the lack of correlation between uEPX/c and percentage of sputum eosinophils, or ECP levels in sputum supernatant, could be due to the wide scatter of uEPX. However, all urine samples were immediately stored at -20degreesC and uEPX and urinary creatinine levels measurements were performed in a central laboratory (Leiden University Medical Hospital) to reduce variability in the analysis. All EPX measurements were done in duplicate and the within-subject reproducibility of uEPX levels was good.
###end p 40
###begin p 41
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
It has been reported that in atopic dermatitis, concentrations of eosinophil- specific mediators, including uEPX/c, are increased [27, 28]. However, we found that the presence or absence of atopic eczema did not influence the correlations between uEPX/c and the percentage eosinophils or ECP in induced sputum. We cannot exclude that heterogeneity of study groups with respect to other atopic disorders than asthma could have affected the correlation between uEPX/c and other markers of eosinophilic airways inflammation.
###end p 41
###begin p 42
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
At the onset of our study, a circadian rhythm of uEPX/c had not been reported. Urine samples were not all obtained at the same time of the day. Since the start of our study, it became evident that a circadian rhythm of uEPX/c with lowest levels at 7 p.m. and highest at 7 a.m. in both asthmatic and healthy controls exists [23, 29-31]. Hence, diurnal variability may have introduced scatter of uEPX, thus weakening a possible correlation.
###end p 42
###begin p 43
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 200 202 200 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 254 256 254 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 476 478 476 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
Two previous studies reported significant positive correlations between uEPX/c and FENO in corticosteroid-dependent childhood asthma [11, 29]. We found no significant correlation between uEPX/c and FENO in a small subgroup of the study population. For FENO, no important circadian variation was found, employing the same measurement technique that we have used [32], but conflicting results have also been published [27, 33]. A possible circadian rhythm might have affected FENO and weakened any cross-sectional relationship.
###end p 43
###begin p 44
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 139 141 139 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 317 319 317 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 357 359 357 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
###xml 335 343 <span type="species:ncbi:9606">children</span>
###xml 621 629 <span type="species:ncbi:9606">children</span>
In conclusion, the present data show a weak inverse correlation between uEPX/c and FEV1, and a borderline correlation between uEPX/c and PD20 methacholine. No significant correlation was found between uEPX/c and markers of eosinophilic airway inflammation including % eosinophils or ECP levels in induced sputum or FENO. The number of children performing FENO was small, therefore this correlation should be interpreted with caution. Our findings are not encouraging for uEPX/c as a complementary marker of airway inflammation in asthma. As to whether uEPX/c can be useful as a marker for monitoring asthma management in children is worth prospectively looking at.
###end p 44
###begin title 45
APPENDIX
###end title 45
###begin p 46
This work has been prepared by the authors on behalf of the CATO Study Group.
###end p 46
###begin p 47
CATO Study Group Members
###end p 47
###begin p 48
###xml 99 107 <span type="species:ncbi:9606">Children</span>
###xml 622 630 <span type="species:ncbi:9606">Children</span>
###xml 1390 1398 <span type="species:ncbi:9606">Children</span>
M. Nuijsink M.D. and J. M. Kouwenberg M.D. (Department of Paediatric Respiratory Medicine, Juliana Children's Hospital, The Hague). W. C. J. Hop Ph.D. (Department of Epidemiology and Biostatistics, Erasmus University Medical Centre, Rotterdam). Professor P. J. Sterk Ph.D. and E. R. V. M. Rikkers-Mutsaerts M.D. (Academic Medical Center, Amsterdam). Professor E. J. Duiverman M.D. Ph.D. (Department of Paediatric Respiratory Diseases, University Medical Centre Groningen, University Groningen). Professor J. C. de Jongste M.D. Ph.D. (Department of Paediatric Respiratory Medicine, Erasmus University Medical Centre/Sophia Children's Hospital, Rotterdam). O. H. van der Baan-Slootweg M.D. and E. E. M. van Essen-Zandvliet M.D. Ph.D. (Asthma Center Heideheuvel, Hilversum). N. J. van den Berg M.D. (Flevo Hospital, Almere). Professor Dr. J. M. Boogaard Ph.D. P. L. P. Brand M.D. Ph.D., R. J. Roorda M.D. Ph.D., and A. W. A. Kamps M.D. Ph.D. (Isala Klinieken, Zwolle). G. Brinkhorst M.D. (Medical Center, Alkmaar). J. E. Dankert-Roelse M.D. Ph.D. and A. F. Nagelkerke M.D. (VU Medical Center, Amsterdam). R. van Gent M.D. (Maxima Medical Center, Veldhoven). J. W. C. M. Heijnens M.D. (Maasland Hospital, Sittard). J. J. E. Hendriks M.D. Ph.D. and Q. Jobsis M.D. Ph.D. (University Hospital Maastricht). J. van der Laag M.D. and H. J. L. Brackel M.D. Ph.D. (University Medical Center/Wilhelmina Children's Hospital, Utrecht). J. C. van Nierop M.D. (Academic Medical Centre, Amsterdam). A. A. P. H. Vaessen-Verberne M.D. Ph.D. (Amphia Hospital, Breda).
###end p 48
###begin title 49
ACKNOWLEDGEMENTS
###end title 49
###begin p 50
The authors would like to thank Bram van der Linden for technical assistance of uEPX and ECP analyses, and Hilly van der Veen for counting the sputum cytospin slides, and also H. C. R. Vermeij for measuring urinary creatinine levels. This study was supported by GlaxoSmithKline.
###end p 50
###begin article-title 51
Childhood- versus adult-onset asthma
###end article-title 51
###begin article-title 52
###xml 38 46 <span type="species:ncbi:9606">children</span>
###xml 97 105 <span type="species:ncbi:9606">children</span>
Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
###end article-title 52
###begin article-title 53
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
###end article-title 53
###begin article-title 54
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
###end article-title 54
###begin article-title 55
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
###end article-title 55
###begin article-title 56
Use of induced sputum to examine airway inflammation in childhood asthma
###end article-title 56
###begin article-title 57
###xml 80 88 <span type="species:ncbi:9606">children</span>
Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children
###end article-title 57
###begin article-title 58
###xml 49 57 <span type="species:ncbi:9606">children</span>
Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate
###end article-title 58
###begin article-title 59
###xml 137 142 <span type="species:ncbi:9606">human</span>
Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay an purification from normal human urine
###end article-title 59
###begin article-title 60
Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo
###end article-title 60
###begin article-title 61
NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma
###end article-title 61
###begin article-title 62
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 64 72 <span type="species:ncbi:9606">children</span>
Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma
###end article-title 62
###begin article-title 63
###xml 47 55 <span type="species:ncbi:9606">children</span>
Eosinophils and eosinophil-derived proteins in children with moderate asthma
###end article-title 63
###begin article-title 64
###xml 32 40 <span type="species:ncbi:9606">children</span>
Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment
###end article-title 64
###begin article-title 65
###xml 39 47 <span type="species:ncbi:9606">children</span>
Measurement of exhaled nitric oxide in children, 2001
###end article-title 65
###begin article-title 66
Lung volumes and forced ventilatory flows. Report Working Party Standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
###end article-title 66
###begin article-title 67
###xml 17 25 <span type="species:ncbi:9606">children</span>
Lung function in children and adolescents. Methods and reference values
###end article-title 67
###begin article-title 68
###xml 103 111 <span type="species:ncbi:9606">children</span>
Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age?
###end article-title 68
###begin article-title 69
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation
###end article-title 69
###begin article-title 70
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma
###end article-title 70
###begin article-title 71
Urinary eosinophil protein X in relation to disease activity in childhood asthma
###end article-title 71
###begin article-title 72
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack
###end article-title 72
###begin article-title 73
###xml 66 74 <span type="species:ncbi:9606">children</span>
Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough
###end article-title 73
###begin article-title 74
Allergen avoidance at high altitude and urinary eosinophil protein X
###end article-title 74
###begin article-title 75
###xml 26 34 <span type="species:ncbi:9606">children</span>
Fluticasone propionate in children with moderate asthma
###end article-title 75
###begin article-title 76
Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?
###end article-title 76
###begin article-title 77
###xml 32 40 <span type="species:ncbi:9606">children</span>
Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity
###end article-title 77
###begin article-title 78
###xml 70 77 <span type="species:ncbi:9606">infants</span>
###xml 88 96 <span type="species:ncbi:9606">children</span>
Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity
###end article-title 78
###begin article-title 79
###xml 102 110 <span type="species:ncbi:9606">children</span>
Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children
###end article-title 79
###begin article-title 80
###xml 77 85 <span type="species:ncbi:9606">children</span>
Circadian variation of urinary eosinophil protein X in asthmatic and healthy children
###end article-title 80
###begin article-title 81
Circadian rhythm of U-EPX
###end article-title 81
###begin article-title 82
###xml 89 97 <span type="species:ncbi:9606">children</span>
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
###end article-title 82
###begin article-title 83
Daily ambulatory exhaled nitric oxide measurements in asthma
###end article-title 83
###begin p 84
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Scatter plot of urinary eosinophil protein X per mmol creatinine (uEPX-c) versus forced expiratory volume in 1 second (FEV1), n = 174.
###end p 84
###begin p 85
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 110 112 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 237 239 237 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
Characteristics of study subjects. Values are median (range). FEV1 is forced expiratory volume in 1 second; PD20 methacholine is provocative dose of methacholine causing FEV1 fall 20% from baseline; ECP is eosinophil cationic protein; FENO is fractional concentration of nitric oxide in exhaled air; uEPX/c is urinary eosinophil protein X per mmol creatinine.
###end p 85
###begin p 86
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 242 243 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 287 289 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 414 416 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NO</sub>
Correlations between uEPX or uEPX-c and clinical markers of asthma severity or markers of asthmatic inflammation. r values were all analyzed by Spearman's rank correlation tests. uEPX/c is urinary eosinophil protein X per mmol creatinine; FEV1 is forced expiratory volume in 1 second; PD20 methacholine is provocative dose of methacholine causing FEV1 fall 20% from baseline; ECP is eosinophil cationic protein; FENO is fractional concentration of nitric oxide in exhaled air.
###end p 86

